Israel has been held up as the “gold standard” of how to conduct the coronavirus vaccine rollout. It has seen approximately 70% of its population receive the jab. The Israelis have relied in the main on the Pfizer vaccine. However, recently the country’s Prime Minister, Naftali Bennett, stated that the Pfizer vaccine is ‘significantly less’ effective against the so-called Delta variant. This follows on from a statement last June by Ran Balicer, who leads an expert advisory panel for the Israeli government, in announcing that the country might end up in lockdown again.
Already a subscriber? Log in
Easter flash sale:
10 issues for $1
Subscribe this Easter and get the next 10 issues of the magazine, plus website and app access, all for just $1.
- Weekly delivery of the magazine
- Unlimited access to spectator.com.au and app
- Spectator Australia podcasts and newsletters
- Full access to spectator.co.uk
Comments
Easter flash sale: 10 issues for $1
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
CLAIM OFFER 10 issues for $1Already a subscriber? Log in